|Statement||formal papers and selected edited discussion drawn from the Brook Lodge Symposium, Augusta, Michigan. Edited by Edward M. Southern.|
|Contributions||Southern, Edward M., 1918- ed., Upjohn Company.|
|LC Classifications||QP801.P68 I58 1972|
|The Physical Object|
|Pagination||xiii, 545, xxviii p.|
|Number of Pages||545|
|LC Control Number||72093462|
The role of prostaglandins in physiological events and pathological disorders related to human reproduction has been most actively investigated in the past decade. Their clinical use for fertility regulation, extensively evaluated, represents the most common clinical indication for the administration of these remarkable compounds. Clinical application of prostaglandins in human reproduction. Toppozada MK. PIP: In this discussion of the clinical application of prostaglandins (PGs) in human reproduction, attention is directed to indications for PG administration, potential therapeutic applications, PG drugs, routes and schedules of PG administration, contraindications to PG administration, and side effects and by: 4. This book is essentially an interpretative review of the role of prostaglandins in reproduction in farm and laboratory mammals, poultry, fish and primates. Its chapters cover the chemistry of prostaglandins, their role in the male, and that in the release of gonadotropins, ovulation and luteinisation, luteolysis, pregnancy, parturition and by: Clinical observations with a prostaglandin-containing silastic vaginal device for pregnancy termination. Prostaglandins. ; 12 (Suppl)– Lauersen NH, Wilson KH. The abortifacient effectiveness and plasma prostaglandin concentrations with 15(S)methyl prostaglandin F2alpha methyl ester-containing vaginal silastic devices.
Abstract. The use of prostaglandins in obstetrics and gynaecology is now firmly established. Most applications in this area are based on the ability of prostaglandins to modify the activity of the human uterus. This property was first recognized in and has since been confirmed by numerous investigators using pure prostaglandins. Human Reproductive Genetics: Emerging Technologies and Clinical Applications presents a great reference for clinicians and researchers in reproductive medicine. Part I includes a brief background of genetics and epigenetics, probability of disease, and the different techniques that are being used today for analysis and genetic counseling. The cells were exposed to hyperosmolar glucose ( mg/ml), methyl-prostaglandin-F 2α (m-PGF 2α; 10−7 to 10−3 mol/l) and prostaglandin-F 2α (PGF 2α; 10−5 to 5X10−3 mol/l) for 30 min on days 2–4 after seeding. The effects on the secretion of human chorionic gonadotrophin (HCG) and progesterone, as well as on the protein. Human Reproduction: Updates and New Horizons focuses on recent developments and new approaches to study egg and sperm cells and embryo development, as well as addressing the increasing demand for IVF and ART to overcome infertility problems of various kinds that are encountered by an increasing number of couples worldwide. The book includes
The Prostaglandins, edited by Dr. Southern, is a compendium of papers and discussion presented at the Brook Lodge Symposium on Prostaglandins held in June , dealing almost exclusively with the uses of the prostaglandins for termination of pregnancy. It is thus primarily a text useful to the clinician. In The Prostaglandins, Clinical Applications in Human Reproduction. Mt. Kisco, New York, Futura, p 9. S. Eidelman, S.D. Davis, Immunoglobulin content of intestinal plasma-cells in ataxia telangiectasia Lancet 1: () A. Raz, Interaction of prostaglandins with blood plasma proteins Life Sci [I] () Prostaglandins and their clinical applications in human reproduction. Coronavirus: Find the latest articles and preprints Prostaglandins and their clinical applications in human reproduction. Southern EM, Patel NC. The Journal of Reproductive Medicine, 01 Dec , 9(6): PMID: KEITH HlLUER University of Southampton England ix Preface This book is an appraisal of areas in human reproduction where eicosanoid studies (prostaglandins, leukotrienes and thromboxanes) are contributing to physiological and pathological awareness and clinical advances.